Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Osteoarthritis Cartilage. 2015 Sep 26;24(2):299–306. doi: 10.1016/j.joca.2015.09.005

Table 2. Immunogenicity/Neutralization Assessment of Serum 16 weeks after DMM.

Sensor Loading Step Serum Binding Step ADAMTS-5 Binding Step anti-Mouse Binding Step
Sensor mAb Binding (nm Shift) Serum Sample ID (Mouse # / Treatment) Serum Binding (nm Shift) ADAMTS-5 Binding (nm Shift) anti-Mouse IgG Binding (nm Shift)
A1 4.56144 1425/IgG2c mAb 0.7295 2.07617 1.65979
B1 4.47963 1426/ADAMTS-5 mAb 0.48773 2.21794 1.67662
C1 4.71362 1464/No Injection 0.38654 2.3458 1.69864
D1 4.633 1465/No Injection 1.10738 2.03582 1.49423
E1 4.72779 1466/ADAMTS-5 mAb 0.47894 2.21242 1.64249
F1 4.67933 1467/IgG2c mAb 0.67129 2.18379 1.56537
G1 4.47408 1505/ADAMTS-5 mAb 0.89388 2.01044 1.60488
H1 4.54082 1507/IgG2c mAb 0.65863 2.09008 1.64701
HHS Vulnerability Disclosure